Amphastar Pharmaceuticals Inc. (AMPH)

19.95
0.01 0.05
NASDAQ : Health Technology
Prev Close 19.96
Open 19.91
Day Low/High 19.80 / 20.10
52 Wk Low/High 17.71 / 25.43
Volume 202.84K
Avg Volume 217.60K
Exchange NASDAQ
Shares Outstanding 47.23M
Market Cap 941.22M
EPS -0.10
P/E Ratio 18.80
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMPH, KRNT, KTCC, SAFE, SEDG Downgrades: ARNA, CRCM, EPC, IIPR, RGR, RYN, SCWX, SSTI, VCRA Initiations: EPRT, EVER, GSKY, INSP Read on to get TheStreet Quant Ratings' detailed report:

Amphastar Pharmaceuticals Reports Financial Results For The Three Months Ended June 30, 2019

Amphastar Pharmaceuticals Reports Financial Results For The Three Months Ended June 30, 2019

Reports Net Revenues of $79.0 Million for the Three Months Ended June 30, 2019

AMPH Makes Bullish Cross Above Critical Moving Average

AMPH Makes Bullish Cross Above Critical Moving Average

In trading on Monday, shares of Amphastar Pharmaceuticals Inc crossed above their 200 day moving average of $20.82, changing hands as high as $20.83 per share. Amphastar Pharmaceuticals Inc shares are currently trading up about 0.5% on the day.

AMPH Makes Notable Cross Below Critical Moving Average

AMPH Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Amphastar Pharmaceuticals Inc crossed below their 200 day moving average of $20.63, changing hands as low as $20.48 per share. Amphastar Pharmaceuticals Inc shares are currently trading down about 3.4% on the day.

AMPH Makes Notable Cross Below Critical Moving Average

AMPH Makes Notable Cross Below Critical Moving Average

In trading on Wednesday, shares of Amphastar Pharmaceuticals Inc crossed below their 200 day moving average of $20.00, changing hands as low as $19.62 per share. Amphastar Pharmaceuticals Inc shares are currently trading down about 3.9% on the day.

Amphastar Pharmaceuticals Enters Oversold Territory (AMPH)

Amphastar Pharmaceuticals Enters Oversold Territory (AMPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

The Caution Flag Is Out on Speedway Motorsports, Plus 4 Other Stocks That Look Good Short

TRK, AMPH, ICUI, NCI and ABC were all recently downgraded by TheStreet's Quant Ratings service.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NBLX, NOK, OSPN, PATK, PUMP Downgrades: AMPH, CCXI, CXO, FUN, OTIV Initiations: WSC Read on to get TheStreet Quant Ratings' detailed report:

Amphastar Pharmaceuticals Is Now Oversold (AMPH)

Amphastar Pharmaceuticals Is Now Oversold (AMPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMPH, SNA, ZYME Downgrades: LH, SIMO Initiations: LXFR Read on to get TheStreet Quant Ratings' detailed report:

AMPH February 2019 Options Begin Trading

AMPH February 2019 Options Begin Trading

Investors in Amphastar Pharmaceuticals Inc saw new options become available today, for the February 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMPH options chain for the new February 2019 contracts and identified one put and one call contract of particular interest.

AMPH Crosses Above Key Moving Average Level

AMPH Crosses Above Key Moving Average Level

In trading on Tuesday, shares of Amphastar Pharmaceuticals Inc crossed above their 200 day moving average of $18.06, changing hands as high as $18.10 per share. Amphastar Pharmaceuticals Inc shares are currently trading up about 0.2% on the day.

Amphastar Pharmaceuticals Breaks Below 200-Day Moving Average - Notable For AMPH

In trading on Thursday, shares of Amphastar Pharmaceuticals Inc crossed below their 200 day moving average of $18.13, changing hands as low as $16.27 per share. Amphastar Pharmaceuticals Inc shares are currently trading down about 15.8% on the day.

Amphastar Pharmaceuticals Enters Oversold Territory (AMPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2017

Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2017

Reports Net Revenues of $60.4 Million for the Three Months Ended December 31, 2017

Amphastar Pharmaceuticals Reports Financial Results For The Three Months Ended September 30, 2017

Amphastar Pharmaceuticals Reports Financial Results For The Three Months Ended September 30, 2017

Reports Net Revenues of $57.9 Million for the Three Months Ended September 30, 2017

The 6 Medications Being Used to Tackle the Opioid Epidemic

The 6 Medications Being Used to Tackle the Opioid Epidemic

The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

The approval marks "the first new influenza antiviral for pediatric use in over 10 years," said BioCryst president and CEO Jon Stonehouse in the news release.

TheStreet Quant Rating: B- (Buy)